Online Inquiry

Verification code

Biologics Development Services

Our biologics development teams can help accelerate your biologic drug discovery workflow. These comprehensive services include new assay development, modification of existing assays, bioassay optimization and characterization, and biopharmaceutical analysis. BOC Sciences has become a world leader in providing cost-effective and customized services for biologics discovery and development. Our proprietary technology platform makes us highly competitive in the biologics field.

Illustration of a  typical process to develop a mammalian cell line. Figure 1. Illustration of a typical process to develop a mammalian cell line. (Tingfeng, L.; Yuansheng, Y. et al. 2013)

Our Services

To make it easier and better for researchers, BOC Sciences provides biologics development services service in a competitive fashion. We have provided a more efficient way to increase the number of new drugs, greatly shorten the R&D cycle, and reduce the development costs.

ADC Process Development

Antibody-drug conjugates (ADCs) are a new class of biopharmaceutical drugs that use chemical linkers to bind monoclonal antibodies together with highly potent anti-cancer drugs. BOC Sciences has the ability to effectively scale up processes while maintaining Good Manufacturing Practices (GMP) and regulatory compliance. By leveraging our experience in biopharmaceutical process development and scale-up, our team can manufacture highly potent ADCs to support the clinical development and commercial manufacturing of ADCs. We will help you develop, scale up, and optimize processes for ADCs during clinical and commercial production

Oligonucleotide Process Development

Oligonucleotides are rapidly gaining traction as a new class of biotherapeutic agents, offering target specificity and biocompatibility in different medical modalities. BOC Sciences has established a robust oligonucleotides drug production platform to rapidly advance the oligonucleotide development process. We have developed specific strategies for initial characterization, duplex chaperone annealing, secondary structure assessment, sizing and oligomeric state of nucleic acid particles in solution, purity analysis and quantitative detection of primary components and degradation products in raw materials, process samples and final drug substances

Peptide Process Development

Equipped with international standard equipment and instruments, our peptide API process development and GMP manufacturing platform provides end-to-end solutions, and we have built industry-leading capabilities and capacity to support all your needs throughout the product lifecycle

Gene & Cell Therapy Service

With our comprehensive end-to-end portfolio, BOC Sciences has a broad range of cell & gene therapy products and services, as well as the scientific and regulatory expertise to fully support your comprehensive program. We are committed to being your reliable partner in the development of cell & gene therapies. BOC Sciences' experts are able to carefully select species for cell therapy programs, and we offer a wide range of cell models for pilot and safety assessment studies in a range of therapeutic areas, including but not limited to inflammation, bone disease, neuroscience research, and metabolic disease. In addition, we offer custom gene therapy products and services covering the entire development cycle of activities, from plasmid and vector production, to the generation of custom gene models

Enzymes Development

BOC Sciences is dedicated to the development and production of small to large scale specialty enzymes, and our team of experts is able to provide fast and cost-effective speciality enzyme service from discovery phase through to global shipment of regulatory compliant enzymes

Antibody Drug Development

BOC Sciences has a comprehensive range of protein and antibody-based therapeutic products and services to advance drug discovery, from screening drug candidates to custom assays and services

Fluorescence  labeling strategies for different clone screening technologies. Figure 2. Fluorescence labeling strategies for different clone screening technologies. (Tingfeng, L.; Yuansheng, Y. et al. 2013)

Why choose BOC Sciences?

Our dedicated CMC team has provided tailored solutions to our clients from engagement to launch. With many years of industry experience, we provide clients with the following:

  • Comprehensive, integrated CMC services with a flexible service model that grows with your programs
  • Knowledgeable industry experts who deliver scalable, actionable insights
  • World-class facilities and equipment that remain at the forefront of the global pharmaceutical research, analytical and development standards
  • Our comprehensive services support products at every stage of the product lifecycle, from early-stage discovery to full commercial cGMP manufacture
  • A focus on risk management that is designed to ensure completion of your technical goals

BOC Sciences provides professional, rapid and high-quality services of biologics development services at competitive prices for global customers. Personalized and customized services of biologics development services can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!


  1. Tingfeng, L.; Yuansheng, Y. et al. Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production. Pharmaceuticals. 2013. 6(5): 579-603.


Copyright ©  2024  BOC Sciences. All rights reserved.